Clinical Trials Browser

Phase 2 × Has results × Genital Diseases, Female × Clear all

NCT01379534 2015-05-20

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Phase 2 Completed

53 enrolled 10 charts

Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms